Viewing Study NCT01542060


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-02-20 @ 8:08 PM
Study NCT ID: NCT01542060
Status: COMPLETED
Last Update Posted: 2012-04-12
First Post: 2012-02-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 2 View
Keywords: